Unlike CD4+ T cells binding to liver cell MHC-II molecules to form TCR-CD3-peptide-MHC-II complexes, which are later removed from liver cells in autoimmune hepatitis (24), MHC-IIlo/-CD86+ DCs cannot efficiently contact CD4+ T cells. This evidence concerns the gene HLA-C and autoimmune hepatitis.